

<!--XBRL Document Created with Wdesk from Workiva, formerly WebFilings-->
<!-- -->
<linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <roleRef roleURI="http://www.flex-pharma.com/role/AccruedExpensesAndOtherCurrentLiabilities" xlink:href="flks-20141231.xsd#AccruedExpensesAndOtherCurrentLiabilities" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:href="flks-20141231.xsd#AccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:href="flks-20141231.xsd#AccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/CommitmentsAndContingencies" xlink:href="flks-20141231.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/CommitmentsAndContingenciesMinimumFutureLeasePaymentsDetails" xlink:href="flks-20141231.xsd#CommitmentsAndContingenciesMinimumFutureLeasePaymentsDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/CommitmentsAndContingenciesNarrativeDetails" xlink:href="flks-20141231.xsd#CommitmentsAndContingenciesNarrativeDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/CommitmentsAndContingenciesTables" xlink:href="flks-20141231.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/CommonStock" xlink:href="flks-20141231.xsd#CommonStock" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/CommonStockCommonStockTables" xlink:href="flks-20141231.xsd#CommonStockCommonStockTables" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/CommonStockNarrativeDetails" xlink:href="flks-20141231.xsd#CommonStockNarrativeDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/CommonStockRestrictedCommonStockActivityDetails" xlink:href="flks-20141231.xsd#CommonStockRestrictedCommonStockActivityDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/CommonStockSharesReservedForFutureIssuanceDetails" xlink:href="flks-20141231.xsd#CommonStockSharesReservedForFutureIssuanceDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/ConsolidatedBalanceSheet" xlink:href="flks-20141231.xsd#ConsolidatedBalanceSheet" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/ConsolidatedBalanceSheetParenthetical" xlink:href="flks-20141231.xsd#ConsolidatedBalanceSheetParenthetical" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/ConsolidatedStatementOfCashFlows" xlink:href="flks-20141231.xsd#ConsolidatedStatementOfCashFlows" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/ConsolidatedStatementOfConvertiblePreferredStockAndStockholdersDeficit" xlink:href="flks-20141231.xsd#ConsolidatedStatementOfConvertiblePreferredStockAndStockholdersDeficit" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/ConsolidatedStatementOfConvertiblePreferredStockAndStockholdersDeficitParenthetical" xlink:href="flks-20141231.xsd#ConsolidatedStatementOfConvertiblePreferredStockAndStockholdersDeficitParenthetical" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/ConsolidatedStatementOfOperationsAndComprehensiveLoss" xlink:href="flks-20141231.xsd#ConsolidatedStatementOfOperationsAndComprehensiveLoss" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/ConvertiblePreferredStock" xlink:href="flks-20141231.xsd#ConvertiblePreferredStock" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/ConvertiblePreferredStockNarrativeDetails" xlink:href="flks-20141231.xsd#ConvertiblePreferredStockNarrativeDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" xlink:href="flks-20141231.xsd#DocumentAndEntityInformationDocumentAndEntityInformation" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/IncomeTaxes" xlink:href="flks-20141231.xsd#IncomeTaxes" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/IncomeTaxesNarrativeDetails" xlink:href="flks-20141231.xsd#IncomeTaxesNarrativeDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="flks-20141231.xsd#IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:href="flks-20141231.xsd#IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/IncomeTaxesTables" xlink:href="flks-20141231.xsd#IncomeTaxesTables" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/NetLossPerShare" xlink:href="flks-20141231.xsd#NetLossPerShare" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/NetLossPerShareDetails" xlink:href="flks-20141231.xsd#NetLossPerShareDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/NetLossPerShareTables" xlink:href="flks-20141231.xsd#NetLossPerShareTables" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/OrganizationAndOperations" xlink:href="flks-20141231.xsd#OrganizationAndOperations" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/OrganizationAndOperationsDetails" xlink:href="flks-20141231.xsd#OrganizationAndOperationsDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/PropertyAndEquipmentNet" xlink:href="flks-20141231.xsd#PropertyAndEquipmentNet" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/PropertyAndEquipmentNetDetails" xlink:href="flks-20141231.xsd#PropertyAndEquipmentNetDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/PropertyAndEquipmentNetTables" xlink:href="flks-20141231.xsd#PropertyAndEquipmentNetTables" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/QuarterlyFinancialInformationUnaudited" xlink:href="flks-20141231.xsd#QuarterlyFinancialInformationUnaudited" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/QuarterlyFinancialInformationUnauditedDetails" xlink:href="flks-20141231.xsd#QuarterlyFinancialInformationUnauditedDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/QuarterlyFinancialInformationUnauditedTables" xlink:href="flks-20141231.xsd#QuarterlyFinancialInformationUnauditedTables" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/RelatedParty" xlink:href="flks-20141231.xsd#RelatedParty" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/RelatedPartyDetails" xlink:href="flks-20141231.xsd#RelatedPartyDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/RestrictedCash" xlink:href="flks-20141231.xsd#RestrictedCash" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/RestrictedCashDetails" xlink:href="flks-20141231.xsd#RestrictedCashDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/StockBasedCompensation" xlink:href="flks-20141231.xsd#StockBasedCompensation" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/StockBasedCompensationNarrativeDetails" xlink:href="flks-20141231.xsd#StockBasedCompensationNarrativeDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/StockBasedCompensationScheduleOfFairValueAssumptionsDetails" xlink:href="flks-20141231.xsd#StockBasedCompensationScheduleOfFairValueAssumptionsDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails" xlink:href="flks-20141231.xsd#StockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/StockBasedCompensationSummaryOfStockOptionActivityDetails" xlink:href="flks-20141231.xsd#StockBasedCompensationSummaryOfStockOptionActivityDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/StockBasedCompensationTables" xlink:href="flks-20141231.xsd#StockBasedCompensationTables" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/SubsequentEvents" xlink:href="flks-20141231.xsd#SubsequentEvents" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/SubsequentEventsDetails" xlink:href="flks-20141231.xsd#SubsequentEventsDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="flks-20141231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/SummaryOfSignificantAccountingPoliciesDepreciationOverEstimatedUsefulLifeDetails" xlink:href="flks-20141231.xsd#SummaryOfSignificantAccountingPoliciesDepreciationOverEstimatedUsefulLifeDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" xlink:href="flks-20141231.xsd#SummaryOfSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="flks-20141231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
  <roleRef roleURI="http://www.flex-pharma.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="flks-20141231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/AccruedExpensesAndOtherCurrentLiabilities" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/AccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <loc xlink:href="flks-20141231.xsd#flks_AccruedExpensesAndOtherCurrentLiabilities" xlink:label="loc_flks_AccruedExpensesAndOtherCurrentLiabilities_290b1c63-9c29-11e4-a13c-22000a9f3af2" xlink:type="locator" />
    <loc xlink:href="flks-20141231.xsd#flks_AccruedResearchAndDevelopmentExpenseCurrent" xlink:label="loc_flks_AccruedResearchAndDevelopmentExpenseCurrent_0ab42ca5-bcaf-4748-e785-ca6ed74dc429" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_flks_AccruedExpensesAndOtherCurrentLiabilities_290b1c63-9c29-11e4-a13c-22000a9f3af2" xlink:to="loc_flks_AccruedResearchAndDevelopmentExpenseCurrent_0ab42ca5-bcaf-4748-e785-ca6ed74dc429" xlink:type="arc" />
    <loc xlink:href="flks-20141231.xsd#flks_DeferredIPOIssuanceCostCurrent" xlink:label="loc_flks_DeferredIPOIssuanceCostCurrent_60ec0030-bf07-05ec-8028-ca6ed74dffa2" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_flks_AccruedExpensesAndOtherCurrentLiabilities_290b1c63-9c29-11e4-a13c-22000a9f3af2" xlink:to="loc_flks_DeferredIPOIssuanceCostCurrent_60ec0030-bf07-05ec-8028-ca6ed74dffa2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_28c626c7-9023-e30f-2e48-0f4dd115d912" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_flks_AccruedExpensesAndOtherCurrentLiabilities_290b1c63-9c29-11e4-a13c-22000a9f3af2" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_28c626c7-9023-e30f-2e48-0f4dd115d912" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_d69c5cc5-fc70-31a7-c2b1-924eb363b75b" xlink:type="locator" />
    <calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_flks_AccruedExpensesAndOtherCurrentLiabilities_290b1c63-9c29-11e4-a13c-22000a9f3af2" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_d69c5cc5-fc70-31a7-c2b1-924eb363b75b" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccruedMarketingCostsCurrent" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_53fe0802-e552-e21f-68c7-b9003178737a" xlink:type="locator" />
    <calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_flks_AccruedExpensesAndOtherCurrentLiabilities_290b1c63-9c29-11e4-a13c-22000a9f3af2" xlink:to="loc_us-gaap_AccruedMarketingCostsCurrent_53fe0802-e552-e21f-68c7-b9003178737a" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_46c5e103-584b-b600-2852-4201435cc29f" xlink:type="locator" />
    <calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_flks_AccruedExpensesAndOtherCurrentLiabilities_290b1c63-9c29-11e4-a13c-22000a9f3af2" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_46c5e103-584b-b600-2852-4201435cc29f" xlink:type="arc" />
  </calculationLink>
  <calculationLink xlink:role="http://www.flex-pharma.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/CommitmentsAndContingencies" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/CommitmentsAndContingenciesMinimumFutureLeasePaymentsDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_cc811211-f8d9-2df0-b015-05419b9bfc99" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_a329292c-67ac-0030-2d90-e18d188691fe" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_cc811211-f8d9-2df0-b015-05419b9bfc99" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_a329292c-67ac-0030-2d90-e18d188691fe" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_d0d481f0-55e7-c97c-ec8d-df7b34e55256" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_cc811211-f8d9-2df0-b015-05419b9bfc99" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_d0d481f0-55e7-c97c-ec8d-df7b34e55256" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_b90d3e1a-4d8a-a6c8-154e-2ac9658c1ba3" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_cc811211-f8d9-2df0-b015-05419b9bfc99" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_b90d3e1a-4d8a-a6c8-154e-2ac9658c1ba3" xlink:type="arc" />
  </calculationLink>
  <calculationLink xlink:role="http://www.flex-pharma.com/role/CommitmentsAndContingenciesNarrativeDetails" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/CommitmentsAndContingenciesTables" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/CommonStock" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/CommonStockCommonStockTables" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/CommonStockNarrativeDetails" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/CommonStockRestrictedCommonStockActivityDetails" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/CommonStockSharesReservedForFutureIssuanceDetails" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/ConsolidatedBalanceSheet" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaap_StockholdersEquity_26e56c7a-24ab-e869-809a-0509ccbe86d9" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaap_CommonStockValue_ffd09989-75a8-4713-beb0-21bebb3561d6" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_26e56c7a-24ab-e869-809a-0509ccbe86d9" xlink:to="loc_us-gaap_CommonStockValue_ffd09989-75a8-4713-beb0-21bebb3561d6" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaap_AdditionalPaidInCapital_dcbd5d14-4ec6-06fe-e5c1-a41efced6761" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_26e56c7a-24ab-e869-809a-0509ccbe86d9" xlink:to="loc_us-gaap_AdditionalPaidInCapital_dcbd5d14-4ec6-06fe-e5c1-a41efced6761" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_440a13e9-e4dc-f397-4d0d-27daacd44483" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_26e56c7a-24ab-e869-809a-0509ccbe86d9" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_440a13e9-e4dc-f397-4d0d-27daacd44483" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaap_Assets_b517a4f1-4597-b094-2608-75af660328e1" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaap_AssetsCurrent_67f49e84-05fd-4b0b-ae5a-e9913b97cea2" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b517a4f1-4597-b094-2608-75af660328e1" xlink:to="loc_us-gaap_AssetsCurrent_67f49e84-05fd-4b0b-ae5a-e9913b97cea2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaap_Cash_ed1351d7-08ed-47ff-642b-430da354f5e2" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_67f49e84-05fd-4b0b-ae5a-e9913b97cea2" xlink:to="loc_us-gaap_Cash_ed1351d7-08ed-47ff-642b-430da354f5e2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3227d5e9-cb9d-fda7-e599-c6fb89b5e07a" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_67f49e84-05fd-4b0b-ae5a-e9913b97cea2" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3227d5e9-cb9d-fda7-e599-c6fb89b5e07a" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a1eaafaf-055b-e423-85ef-4424fb2ef4e4" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b517a4f1-4597-b094-2608-75af660328e1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a1eaafaf-055b-e423-85ef-4424fb2ef4e4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_4599c23a-11f0-4277-ea32-9886d26f8792" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b517a4f1-4597-b094-2608-75af660328e1" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_4599c23a-11f0-4277-ea32-9886d26f8792" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsNetNoncurrent" xlink:label="loc_us-gaap_DeferredTaxAssetsNetNoncurrent_845254ea-8acf-3ce8-9356-c6d0b076c3a8" xlink:type="locator" />
    <calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b517a4f1-4597-b094-2608-75af660328e1" xlink:to="loc_us-gaap_DeferredTaxAssetsNetNoncurrent_845254ea-8acf-3ce8-9356-c6d0b076c3a8" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_913601c5-bb02-9f7f-1683-87bdfa12cca4" xlink:type="locator" />
    <calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b517a4f1-4597-b094-2608-75af660328e1" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_913601c5-bb02-9f7f-1683-87bdfa12cca4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_24a9334e-39d3-bf69-8cc1-15212ef72c7b" xlink:type="locator" />
    <calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b517a4f1-4597-b094-2608-75af660328e1" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_24a9334e-39d3-bf69-8cc1-15212ef72c7b" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaap_Liabilities_16ce0436-3b82-55c5-d896-5cba4c9023bd" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaap_LiabilitiesCurrent_1477e02d-b6d8-3df6-e715-8364fedce6d9" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_16ce0436-3b82-55c5-d896-5cba4c9023bd" xlink:to="loc_us-gaap_LiabilitiesCurrent_1477e02d-b6d8-3df6-e715-8364fedce6d9" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaap_AccountsPayableCurrent_bd7b63fa-09ae-1100-16fe-5ac027208548" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1477e02d-b6d8-3df6-e715-8364fedce6d9" xlink:to="loc_us-gaap_AccountsPayableCurrent_bd7b63fa-09ae-1100-16fe-5ac027208548" xlink:type="arc" />
    <loc xlink:href="flks-20141231.xsd#flks_AccruedExpensesAndOtherCurrentLiabilities" xlink:label="loc_flks_AccruedExpensesAndOtherCurrentLiabilities_290b1c63-9c29-11e4-a13c-22000a9f3af2" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1477e02d-b6d8-3df6-e715-8364fedce6d9" xlink:to="loc_flks_AccruedExpensesAndOtherCurrentLiabilities_290b1c63-9c29-11e4-a13c-22000a9f3af2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxLiabilitiesCurrent" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesCurrent_712a848e-6493-088e-8a82-029610cac2c5" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1477e02d-b6d8-3df6-e715-8364fedce6d9" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesCurrent_712a848e-6493-088e-8a82-029610cac2c5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRentCreditCurrent" xlink:label="loc_us-gaap_DeferredRentCreditCurrent_23362b02-01cb-51af-a2d0-3af1739fa1db" xlink:type="locator" />
    <calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1477e02d-b6d8-3df6-e715-8364fedce6d9" xlink:to="loc_us-gaap_DeferredRentCreditCurrent_23362b02-01cb-51af-a2d0-3af1739fa1db" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="loc_us-gaap_DeferredRentCreditNoncurrent_55393c1a-fc24-e579-ffe3-04ec8ee0f328" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_16ce0436-3b82-55c5-d896-5cba4c9023bd" xlink:to="loc_us-gaap_DeferredRentCreditNoncurrent_55393c1a-fc24-e579-ffe3-04ec8ee0f328" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_f7fce5cd-2d53-a8b3-a485-6d0f3635b8fe" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_16ce0436-3b82-55c5-d896-5cba4c9023bd" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_f7fce5cd-2d53-a8b3-a485-6d0f3635b8fe" xlink:type="arc" />
  </calculationLink>
  <calculationLink xlink:role="http://www.flex-pharma.com/role/ConsolidatedBalanceSheetParenthetical" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/ConsolidatedStatementOfCashFlows" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b6b5c2f7-2ab7-a264-6d06-119dda52768c" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_faecc408-4bea-6e13-83bd-71b4c2ddf64c" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b6b5c2f7-2ab7-a264-6d06-119dda52768c" xlink:to="loc_us-gaap_NetIncomeLoss_faecc408-4bea-6e13-83bd-71b4c2ddf64c" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaap_Depreciation_296ac298-3acc-b888-34a0-99e6da446889" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b6b5c2f7-2ab7-a264-6d06-119dda52768c" xlink:to="loc_us-gaap_Depreciation_296ac298-3acc-b888-34a0-99e6da446889" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaap_ShareBasedCompensation_aa7a0bc5-86c6-13a8-3676-9960bad8007f" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b6b5c2f7-2ab7-a264-6d06-119dda52768c" xlink:to="loc_us-gaap_ShareBasedCompensation_aa7a0bc5-86c6-13a8-3676-9960bad8007f" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OtherNoncashExpense" xlink:label="loc_us-gaap_OtherNoncashExpense_79825e44-796c-989c-2eb8-3fb929eb4c31" xlink:type="locator" />
    <calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b6b5c2f7-2ab7-a264-6d06-119dda52768c" xlink:to="loc_us-gaap_OtherNoncashExpense_79825e44-796c-989c-2eb8-3fb929eb4c31" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities" xlink:label="loc_us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities_b24a1c7f-fa2c-6aba-5e29-c2fecacee68f" xlink:type="locator" />
    <calculationArc order="5" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b6b5c2f7-2ab7-a264-6d06-119dda52768c" xlink:to="loc_us-gaap_IncreaseDecreaseInRestrictedCashForOperatingActivities_b24a1c7f-fa2c-6aba-5e29-c2fecacee68f" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_07d730ea-b32b-956c-677e-cf5b73c388b0" xlink:type="locator" />
    <calculationArc order="6" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b6b5c2f7-2ab7-a264-6d06-119dda52768c" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_07d730ea-b32b-956c-677e-cf5b73c388b0" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_61010cf2-f381-68a2-d0b7-2785316c9e09" xlink:type="locator" />
    <calculationArc order="7" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b6b5c2f7-2ab7-a264-6d06-119dda52768c" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_61010cf2-f381-68a2-d0b7-2785316c9e09" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_b9fb8522-752c-3209-8cca-60e64f420ad5" xlink:type="locator" />
    <calculationArc order="8" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b6b5c2f7-2ab7-a264-6d06-119dda52768c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_b9fb8522-752c-3209-8cca-60e64f420ad5" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_5cb9a7e8-dd26-27c7-9313-c478703eadea" xlink:type="locator" />
    <calculationArc order="9" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b6b5c2f7-2ab7-a264-6d06-119dda52768c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_5cb9a7e8-dd26-27c7-9313-c478703eadea" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredLiabilities_2a8737e7-4843-3e79-f5bc-ba4bec765cee" xlink:type="locator" />
    <calculationArc order="10" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b6b5c2f7-2ab7-a264-6d06-119dda52768c" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredLiabilities_2a8737e7-4843-3e79-f5bc-ba4bec765cee" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_a785e250-46dd-9933-9ebc-e8177d277129" xlink:type="locator" />
    <calculationArc order="11" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b6b5c2f7-2ab7-a264-6d06-119dda52768c" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_a785e250-46dd-9933-9ebc-e8177d277129" xlink:type="arc" />
  </calculationLink>
  <calculationLink xlink:role="http://www.flex-pharma.com/role/ConsolidatedStatementOfConvertiblePreferredStockAndStockholdersDeficit" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/ConsolidatedStatementOfConvertiblePreferredStockAndStockholdersDeficitParenthetical" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/ConsolidatedStatementOfOperationsAndComprehensiveLoss" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaap_OperatingExpenses_ee2bd36d-150a-7303-38c4-eb755f792210" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_7d1bc05d-33ee-c009-4533-b70ee0a74dc9" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_ee2bd36d-150a-7303-38c4-eb755f792210" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_7d1bc05d-33ee-c009-4533-b70ee0a74dc9" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_7c6d12de-ee49-8fea-ba36-2f44ccb8dae4" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_ee2bd36d-150a-7303-38c4-eb755f792210" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_7c6d12de-ee49-8fea-ba36-2f44ccb8dae4" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaap_NetIncomeLoss_faecc408-4bea-6e13-83bd-71b4c2ddf64c" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_cc64ed8f-51e0-4a92-b0c8-acb3ad13358b" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_faecc408-4bea-6e13-83bd-71b4c2ddf64c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_cc64ed8f-51e0-4a92-b0c8-acb3ad13358b" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_InterestIncomeOperating" xlink:label="loc_us-gaap_InterestIncomeOperating_e7baa765-e731-d3bc-1056-f5623f4a4c01" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_faecc408-4bea-6e13-83bd-71b4c2ddf64c" xlink:to="loc_us-gaap_InterestIncomeOperating_e7baa765-e731-d3bc-1056-f5623f4a4c01" xlink:type="arc" />
  </calculationLink>
  <calculationLink xlink:role="http://www.flex-pharma.com/role/ConvertiblePreferredStock" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/ConvertiblePreferredStockNarrativeDetails" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/DocumentAndEntityInformationDocumentAndEntityInformation" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/IncomeTaxes" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/IncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_406aac40-50cd-6dac-9616-1ad8d5e1be85" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_4c447841-8fe7-39fb-b3f1-0ad85920e353" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_406aac40-50cd-6dac-9616-1ad8d5e1be85" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_4c447841-8fe7-39fb-b3f1-0ad85920e353" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_c6255722-3158-aa8e-fb0b-718e4b04bb3b" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_4c447841-8fe7-39fb-b3f1-0ad85920e353" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_c6255722-3158-aa8e-fb0b-718e4b04bb3b" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_3a1af413-3358-8911-7861-13a95e291501" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_c6255722-3158-aa8e-fb0b-718e4b04bb3b" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_3a1af413-3358-8911-7861-13a95e291501" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_cc073c9b-df99-b1d4-6ac8-8ec231594e51" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_c6255722-3158-aa8e-fb0b-718e4b04bb3b" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_cc073c9b-df99-b1d4-6ac8-8ec231594e51" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_70b5dec9-12bf-951f-98e3-0007ffe2e754" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_c6255722-3158-aa8e-fb0b-718e4b04bb3b" xlink:to="loc_us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment_70b5dec9-12bf-951f-98e3-0007ffe2e754" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_772f9e14-fdcf-0b3c-d185-e9c8ad74796e" xlink:type="locator" />
    <calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_c6255722-3158-aa8e-fb0b-718e4b04bb3b" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_772f9e14-fdcf-0b3c-d185-e9c8ad74796e" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_38ff5a6e-12a8-f8a7-dc1c-73a01b2e8cb3" xlink:type="locator" />
    <calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_c6255722-3158-aa8e-fb0b-718e4b04bb3b" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_38ff5a6e-12a8-f8a7-dc1c-73a01b2e8cb3" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_9afa727c-dfb8-5804-93fa-f0667d5fb87b" xlink:type="locator" />
    <calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_4c447841-8fe7-39fb-b3f1-0ad85920e353" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_9afa727c-dfb8-5804-93fa-f0667d5fb87b" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_576d5a77-ba10-3881-36d9-b5e9bdaefd1b" xlink:type="locator" />
    <calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_406aac40-50cd-6dac-9616-1ad8d5e1be85" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_576d5a77-ba10-3881-36d9-b5e9bdaefd1b" xlink:type="arc" />
    <loc xlink:href="flks-20141231.xsd#flks_DeferredTaxLiabilitiesTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="loc_flks_DeferredTaxLiabilitiesTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_6d82114b-9b3c-11e4-a13c-22000a9f3af2" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_576d5a77-ba10-3881-36d9-b5e9bdaefd1b" xlink:to="loc_flks_DeferredTaxLiabilitiesTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_6d82114b-9b3c-11e4-a13c-22000a9f3af2" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_9606c73c-efc0-b625-54e8-152a5208656a" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_576d5a77-ba10-3881-36d9-b5e9bdaefd1b" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_9606c73c-efc0-b625-54e8-152a5208656a" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals_05eddd02-2c79-0847-4580-12c63cc1e2ad" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_576d5a77-ba10-3881-36d9-b5e9bdaefd1b" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals_05eddd02-2c79-0847-4580-12c63cc1e2ad" xlink:type="arc" />
  </calculationLink>
  <calculationLink xlink:role="http://www.flex-pharma.com/role/IncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5ddb71af-ee72-e71c-9687-36f2fcccd6a2" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_55be6f60-8111-2336-cf66-f877a3b48db1" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5ddb71af-ee72-e71c-9687-36f2fcccd6a2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_55be6f60-8111-2336-cf66-f877a3b48db1" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_72ae94ba-db0a-f76c-be66-6d2c81fa2faa" xlink:type="locator" />
    <calculationArc order="2" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5ddb71af-ee72-e71c-9687-36f2fcccd6a2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_72ae94ba-db0a-f76c-be66-6d2c81fa2faa" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_600e1ce2-d67d-c632-9dc0-17621aaafa46" xlink:type="locator" />
    <calculationArc order="3" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5ddb71af-ee72-e71c-9687-36f2fcccd6a2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_600e1ce2-d67d-c632-9dc0-17621aaafa46" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_a2a6b89f-874c-eb7f-8f7d-6c46aabf3f01" xlink:type="locator" />
    <calculationArc order="4" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5ddb71af-ee72-e71c-9687-36f2fcccd6a2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_a2a6b89f-874c-eb7f-8f7d-6c46aabf3f01" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_7c72534e-ef48-b3cf-6a02-3847687d670a" xlink:type="locator" />
    <calculationArc order="5" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5ddb71af-ee72-e71c-9687-36f2fcccd6a2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_7c72534e-ef48-b3cf-6a02-3847687d670a" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_5650a259-949c-08d2-8466-dfc52c207f21" xlink:type="locator" />
    <calculationArc order="6" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_5ddb71af-ee72-e71c-9687-36f2fcccd6a2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_5650a259-949c-08d2-8466-dfc52c207f21" xlink:type="arc" />
  </calculationLink>
  <calculationLink xlink:role="http://www.flex-pharma.com/role/IncomeTaxesTables" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/NetLossPerShare" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/NetLossPerShareDetails" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/NetLossPerShareTables" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/OrganizationAndOperations" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/OrganizationAndOperationsDetails" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/PropertyAndEquipmentNet" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/PropertyAndEquipmentNetDetails" xlink:type="extended">
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a1eaafaf-055b-e423-85ef-4424fb2ef4e4" xlink:type="locator" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_c4121e9a-097d-7136-dbac-b93469330286" xlink:type="locator" />
    <calculationArc order="1" weight="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_a1eaafaf-055b-e423-85ef-4424fb2ef4e4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_c4121e9a-097d-7136-dbac-b93469330286" xlink:type="arc" />
    <loc xlink:href="http://xbrl.fasb.org/us-gaap/2014/elts/us-gaap-2014-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2c0591e3-817a-5563-df1e-5c3ede33266d" xlink:type="locator" />
    <calculationArc order="2" weight="-1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_a1eaafaf-055b-e423-85ef-4424fb2ef4e4" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2c0591e3-817a-5563-df1e-5c3ede33266d" xlink:type="arc" />
  </calculationLink>
  <calculationLink xlink:role="http://www.flex-pharma.com/role/PropertyAndEquipmentNetTables" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/QuarterlyFinancialInformationUnaudited" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/QuarterlyFinancialInformationUnauditedDetails" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/QuarterlyFinancialInformationUnauditedTables" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/RelatedParty" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/RelatedPartyDetails" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/RestrictedCash" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/RestrictedCashDetails" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/StockBasedCompensation" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/StockBasedCompensationScheduleOfFairValueAssumptionsDetails" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/StockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/StockBasedCompensationSummaryOfStockOptionActivityDetails" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/StockBasedCompensationTables" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/SubsequentEvents" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/SubsequentEventsDetails" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/SummaryOfSignificantAccountingPolicies" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/SummaryOfSignificantAccountingPoliciesDepreciationOverEstimatedUsefulLifeDetails" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="extended" />
  <calculationLink xlink:role="http://www.flex-pharma.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:type="extended" />
</linkbase>





